HKPD vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

HKPD

42.9
AI Score
VS
NIVF Wins

NIVF

51.9
AI Score

Investment Advisor Scores

HKPD

43score
Recommendation
HOLD

NIVF

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HKPD NIVF Winner
Forward P/E 0 0.0366 Tie
PEG Ratio 0 0 Tie
Revenue Growth -31.7% 11.9% NIVF
Earnings Growth -83.1% 0.0% NIVF
Tradestie Score 42.9/100 51.9/100 NIVF
Profit Margin -8.5% 209.0% NIVF
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HKPD 1M: +6.5% · 3M: -26.6% NIVF 1M: -55.2% · 3M: -51.6%

Current Technical Phase

HKPD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.3%), weak momentum, RSI 45

RSI (14): 44.7 · Price: $0.39

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.9%), weak momentum, RSI 33

RSI (14): 33.4 · Price: $0.49

Fundamentals Snapshot

Metric HKPD NIVF
Market Cap
Forward P/E 0.0 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth -0.3% 0.1%
Gross Margin 0.1% 0.2%
Operating Margin -0.2% -3.5%
EPS -0.07 108.08
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.